Amarantus Bioscience Holdings Inc (AMBS)

[Solantey]

A reverse split will eventually take it to .50.

It's my understanding that the preferred shares convert to about 200,000,000 common shares. I assume those are all owned by Gerald.

Anytime you try to value the company for a buyout the minimum number of shares to be used is in the 425,000,000 range and headed higher.

Without a buyout/partnership use the entire 1,000,000,000 shares and factor in 2-3 reverse split to fund the company for the next seven years if the MANF technology is to produce a marketable drug funded by the company.